Dexilant SoluTab dissolvable tablets: disease state leave-behind
Swallowing pills is a struggle for many patients, especially for those who suffer from GERD and erosive esophagitis. This leave-behind piece highlights the issue for doctors and reminds them that there are alternative formulations, like dissolvable tablets, that could make swallowing easier for their patients.
(Use arrows to see reverse side.)
(Use arrows to see reverse side.)
Amitiza: chronic constipation: patient education brochure
(Use arrows to see additional pages.)
Dexilant: GERD: patient education brochure
(Use arrows to see additional pages.)
Contrave: obesity: patient website
For people who suffer from obesity, there's often a stigma around taking a weight-loss drug. But losing weight often takes more than just will power. This supportive, responsive site brings the Contrave campaign to life, focusing on patients who are ready to make a commitment to long-term weight loss.
(Use arrows to see additional pages.)
(Use arrows to see additional pages.)
PediaSure
Quanterix Portfolio
Quanterix is a research and diagnostics company that develops assays and instrumentation and is known for its ultra-sensitive biomarker detection capabilities. This campaign highlights three different products within the company's portfolio, each of which provides different avenues for early disease detection, better prognoses, and enhanced treatment methods.
